Danish drugmaker Novo Nordisk has been affected by a third fire in a month, the latest involving an office building near its Copenhagen headquarters. The latest fire started at a three-storey ...

(Bloomberg) -- Novo Nordisk A/S, the maker of Ozempic and Wegovy, lost an office building at its Danish headquarters complex due to a massive fire, in the second blaze to hit the drugmaker in less ...

Headquarters of pharmaceutical company Novo Nordisk in Copenhagen, Denmark, on Sept. 26, 2023. (Tom Little/File photo / Reuters Photos) In the latest trial that spanned 68 weeks, 61.9% of patients ...

(Bloomberg) -- Novo Nordisk A/S has halted roof repairs across ... 16 appears to be unrelated to this week’s blaze at Novo’s headquarters outside Copenhagen. “We will not make any roof ...

March 28, 2025 Novo Nordisk to license obesity drug from Lexicon in up to $1 billion deal Novo Nordisk is licensing Lexicon Pharmaceuticals' experimental obesity drug in a deal worth up to $1 ...